Selenium Supplementation and Cancer Prevention

Current Nutrition Reports

Volumn 1, Issue 1, 2012, Pages 16-23

  Davis, Cindy D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer prevention; Nutritional prevention of cancer trial; SELECT trial; Selenium; Selenoproteins; Supplementation

Indexed keywords

ALPHA TOCOPHEROL; BRCA1 PROTEIN; SELENITE; SELENIUM; SELENOMETHIONINE; SELENOPROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHRONIC TOXICITY; COLORECTAL CANCER; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG MEGADOSE; FOLLOW UP; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LIVER CANCER; LUNG CANCER; LYMPH NODE METASTASIS; METABOLISM; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN CANCER;

EID: 84886753386     PISSN: None     EISSN: 21613311     Source Type: Journal    
DOI: 10.1007/s13668-011-0003-x     Document Type: Article

References (79)

1. Franke KW. A new toxicant occurring naturally in certain samples of plant foodstuffs. I. Results obtained in preliminary feeding trials. J Nutr. 1934; 8: 597-608.
2. Nelson AA, Fitzhugh OG, Calvery HO. Liver tumors following cirrhosis caused by selenium in rats. Cancer Res. 1943; 3: 230-6.
3. Schwarz K, Foltz CM. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Amer Chem Soc. 1957; 79: 3292-3.
4. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969; 100: 682.
5. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973; 179: 588-90.
6. Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science. 2003; 300: 1439-43.
7. Panel on Dietary Antioxidants and Related Compounds, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press Washington. 2000; 506.
8. Chun OK, Floegel A, Chung SJ, et al. Estimation of antioxidant intakes from diet and supplements in U. S. adults. J Nutr. 2010; 140: 317-24.
9. Schubert A, Holden JM, Wolf WR. Selenium content of a core group of foods based on a critical evaluation of published analytical data. J Amer Dietetic Assoc. 1987; 87: 285-99.
10. Terry N, Zayed AM, deSouza MP, Tarun AS. Selenium in higher plants. Annu Rev Plant Physiol. 2000; 51: 401-32.
11. Whanger PD. Metabolic pathways of selenium in plants and animals and their nutritional significance. In Nutritional Biotechnology in the Feed and Food Industries. Proceedings of Allteck's 19th Annual Symposium Nottingham. Edited by Lyons TP and Jacques KA. Nottingham University Press; 2003; 51-58.
12. Schrauzer GN. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res. 2003; 47: 73-112.
13. Rayman MP. The use of high-selenium yeast to raise selenium status: how does it measure up? Br J Nutr. 2004; 92: 557-73.
14. Ellis DR, Salt DE. Plants, selenium and human health. Curr Opin Plant Biol. 2003; 6: 273-9.
15. Sors TG, Martin CP, Salt DE. Characterization of selenocystein methyltransferases from Astragalus species with contrasting selenium accumulation capacity. Plant J. 2009; 59: 110-22.
16. Cai XJ, Block E, Uden PC, et al. Allium chemistry: identification of selenoamino acids in ordinary and selenium enriched garlic, onion and broccoli using gas chromatography with atomic emission detection. J Agric Food Chem. 1995; 43: 1754-7.
17. Dhillon KS, Dhillon SK. Selenium concentrations of common weeds and agricultural crops grown in the seleniferous soils of northwestern India. Sci Total Environ. 2009; 407: 6150-6.
18. Zhu YG, Pilon-Smits EA, Zhao FJ, Williams PN, Megarg AA. Selenium in higher plants: understanding mechanisms from biofortification and phytoremeidation. Trends Plant Sci. 2009; 14: 436-42.
19. Whanger P, Vendeland S, Park YC, Xia Y. Metabolism of subtoxic levels of selenium in animals and humans. Ann Clin Lab Sci. 1996; 26: 99-113.
20. Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol. 2003; 38: 232-4.
21. Lemire M, Philibert A, Fillion M, et al. No evidence of selenosis from a selenium-rich diet in the Brazilian Amazon. Environ Int. 2011, Epub.
22. Schrauzer GN. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr. 2000; 130: 1653-6.
23. Vendeland SC, Deagen JT, Butler JA, Whanger PD. Uptake of selenite, selenomethionine and selenate by brush border membrane vesicles isolated from rat small intestine. Biometals. 1994; 7: 305-12.
24. Gao Y, Liu Y, Deng G, Wang Z. Distribution of selenium containing proteins in human serum. Biol Trace Elem Res. 2004; 100: 105-15.
25. Schiobara Y, Yoshida T, Suzuki KT. Effects of dietary selenium species on Se concentrations in hair, blood, and urine. Toxicol Appl Pharmacol. 1998; 152: 309-14.
26. Waschulewski IH, Sunde RA. Effect of dietary methionine on tissue selenium and glutathione peroxidase (EC 1. 11. 1. 9) activity in rats given selenomethionine. Br J Nutr. 1988; 60: 57-68.
27. Davis CD, Finley JW. Chemical versus food forms of selenium in cancer prevention. In: Watson RW, editor. Functional foods & nutraceuticals in cancer prevention. Ames: Iowa State Press; 2003. p. 55-86.
28. Ip C, Hayes C, Budnick RM, Ganther HE. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res. 1991; 51: 595-600.
29. Ip C, Ganther HE. Activity of methylated forms of selenium in cancer prevention. Cancer Res. 1990; 50: 1206-11.
30. Ip C, Ganther H. Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite. Carcinogenesis. 1988; 9: 1481-4.
31. Brozmanova J, Minikova D, Vlckova V, Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 2010; 84: 919-38.
32. Gromazinska J, Rszka E, Bruzelius K, et al. Selenium and cancer; biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr. 2008; 47: 29-50.
33. Yang H, Fang J, Jia X, et al. Chemopreventive effects of early-stage and late-stage supplementation of vitamin E and selenium on esophageal carcinogenesis in rats maintained on a low vitamin E/selenium diet. Carcinogenesis. 2011; 32: 381-8.
34. Corcoran NM, Najdovska M, Costello AJ. Inorganic selenium retards progression of experimental hormone refractory prostate cancer. J Urol. 2004; 171: 907-10.
35. Li D, Graef GL, Yee JA, Yan L. Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice. J Nutr. 2004; 134: 1536-40.
36. Waters DJ, Shen S, Cooley DM, et al. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst. 2003; 95: 237-41.
37. Chinag EC, Shen S, Kengeri SS, et al. Defining the optimal selenium dose for prostate cancer risk reduction: insights from the u-shaped relationship between selenium status, DNA damage and apoptosis. Dose-Response. 2009; 8: 285-300.
38. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in U. S. counties. Arch Environ Health. 1991; 46: 37-42.
39. Shamberger RJ, Tytko SA, Willis CE. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health. 1976; 31: 231-5.
40. Yu S-Y, Chu Y-J, Gong X-G, Hou C. Regional variation of cancer mortality incidence and its relation to selenium levels in China. Biol Trace Elem Res. 1985; 67: 21-9.
41. Shamberger RJ, Willis CE. Selenium distribution and human cancer mortality. CRC Crit Rev Clin Lab Sci. 1971; 2: 211-21.
42. Klarod K, Hongsprabhas P, Khampitak T, et al. Serum antioxidant levels and nutritional status in early and advanced stage lung cancer patients. Nutrition 2011, in press.
43. Davis CD, Irons R. Are selenoproteins important for the cancer protective effects of selenium? Current Nutn & Food Sci. 2005; 1: 201-4.
44. Avanzini P, Vinceti M, Ilariucci F, et al. Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies. Haematologica. 1995; 80: 505-11.
45. Deffuant C, Celerier P, Boiteau HL, et al. Serum selenium in melanoma and epidermotropic cutaneous T-cell lymphoma. Acta Derm Venereol. 1994; 74: 90-2.
46. Knekt P, Marniemi J, Teppo L, et al. Is low selenium status a risk factor for lung cancer? Am J Epidemiol. 1998; 148: 975-82.
47. Glattre E, Thomassen Y, Thoresen SO, et al. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol. 1989; 18: 45-9.
48. Wallace K, Byers T, Morris JS, et al. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2003; 12: 464-7.
49. Murphy SJ, Anderson LA, Ferguson HR, et al. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus. J Nutr. 2010; 140: 1757-63.
50. Kotsopoulos J, Chen Z, Vallis KA, et al. Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers. Cancer Causes Control. 2010; 21: 679-87.
51. • Franca CA, Noguiera CR, Ramalho A, et al. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Ann Oncol. 2011; 22: 1109-12. This study suggests that cancer treatment can influence serum Se concentrations.
52. Steevens J, van den Brandt PA, Godbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology. 2010; 138: 1704-13.
53. Allen NE, Appleby PH, Roddam AW, et al. Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2008; 88: 1567-75.
54. Hunter DJ, Morris JS, Stampfer MJ, et al. A prospective study of selenium status and breast cancer risk. JAMA. 1990; 264: 1128-31.
55. Vinceti M, Rothman KJ, Beromi M, et al. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev. 1998; 7: 853-6.
56. Dennett G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database of Syst Rev. 2011; 8: CD005195. This paper provides a comprehensive review and meta-analysis of the prospective studies related to Se and cancer prevention.
57. Brown KM, Pickard K, Nicol F, et al. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clin Sci (Lond). 2000; 98: 593-9.
58. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003; 63: 3347-51.
59. Diwadkar-Navsariwala V, Diamond AM. The link between selenium and chemoprevention: a case for selenoproteins. J Nutr. 2004; 134: 2899-902.
60. Kumaraswamy E, Malykh A, Korotkov KV, et al. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem. 2000; 275: 35540-7.
61. Steinbrecher A, Meplan C, Hesketh J, et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2958-68.
62. Penney KL, Schumacher FR, Li H, et al. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res. 2010; 3: 604-10.
63. Meplan C, Hughes DJ, Pardini B, et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis. 2010; 31: 1074-9.
64. Meplan C, Nicole F, Burtle BT, et al. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, Se intake and cancer status. Antioxidants & Redox Signaling. 2009; 11: 2631-40.
65. Bermano G, Pagmantidis V, Holloway N, et al. Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr. 2007; 2: 225-32.
66. Hu J, Zhou GW, Wang N, Wang YJ. GPX1Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010; 124: 425-31.
67. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997; 56: 117-24.
68. Li W, Zhu Y, Yanx X, et al. The prevention of primary liver cancer by selenium in high risk populations. Zhoghua Yu Fang Yi Xue Za Zhi. 2000; 34: 336-8.
69. Yu SY, Zhu YJ, Li WG, et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res. 1991; 29: 289-94.
70. Clark LC, Combs Jr GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996; 276: 1957-63.
71. Duffield-Lillico AJ, Slate EH, Reid ME, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst. 2003; 95: 1477-81.
72. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002; 11: 630-9.
73. Reid ME, Duffield-Lillico AJ, Garland L, et al. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev. 2002; 11: 1285-91.
74. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003; 91: 608-12.
75. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39-51. This paper describes the largest clinical study of Se supplementation for cancer prevention.
76. Klein EA, Tangen CM, Thompson IM, et al. Vitamin E increases the risk of prostate cancer: updated results of the SWOG-coordinated Selenium and Vitamin E Cancer Prevention trial (SELECT). JAMA, 2011, accepted/embargoed.
77. Fleschner NE, Kapusta L, Donnelly B, et al. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol. 2011; 29: 2386-90.
78. Lee JI, Nian H, Cooper AJ, et al. Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells. Cancer Prev Res. 2009; 2: 683-93.
79. Larsen EH, Hansen M, Paulin H, et al. Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies. J AOAC Int. 2004; 87: 225-32.